US states sue 26 drugmakers over alleged price fixing

A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Sun Pharma to pay $205m over generics price-fixing

24 July 2020 A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.

Americas

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

2 July 2020 Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Generics

Glenmark becomes fifth generic to be charged with US antitrust violations

2 July 2020 Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

More features

AIPPI: Personalised medicine tests the limits in patent law

Ropes & Gray loses 21-attorney group to join rival on growth spree

How 'Boehringer' sets preliminary relief threshold for generics

‘Whose trademark law is AI based on exactly?’: Key questions from Marques

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

US states sue 26 drugmakers over alleged price fixing

More on this story

Editor's picks

Editor's picks

More features